Last update 01 Nov 2024

3H (Suzhou) Pharmaceuticals Co., Ltd

Private Company|
2022|
Jiangsu Sheng, China

Overview

Tags

Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
FGFR2(Fibroblast growth factor receptor 2)1

Related

1
Drugs associated with 3H (Suzhou) Pharmaceuticals Co., Ltd
3HP-2827
Target
FGFR2
Mechanism
FGFR2 antagonists
Active Org.
3H (Shanghai) Pharmaceuticals Co., Ltd3H (Shanghai) Pharmaceuticals Co., Ltd [+1]
Originator Org.
3H (Suzhou) Pharmaceuticals Co., Ltd
Active Indication
FGFR2 Mutation Solid Tumors [+2]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
3
Clinical Trials associated with 3H (Suzhou) Pharmaceuticals Co., Ltd
NCT06378593 / RecruitingPhase 1/2
An Open-Label, Multi-center Phase 1/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Activity of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
CTR20241063 / RecruitingPhase 1/2
3HP-2827在FGFR2异常的手术不可切除/转移性实体瘤患者中的安全性、耐受性、药代动力学和疗效的开放、多中心1/2期临床研究
[Translation] An open-label, multicenter Phase 1/2 clinical study of the safety, tolerability, pharmacokinetics, and efficacy of 3HP-2827 in patients with surgically unresectable/metastatic solid tumors with FGFR2 abnormalities
NCT06287918 / Not yet recruitingPhase 1
A First-in-human, Open-label, Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Activity of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
100 Clinical Results associated with 3H (Suzhou) Pharmaceuticals Co., Ltd
Login to view more data
0 Patents (Medical) associated with 3H (Suzhou) Pharmaceuticals Co., Ltd
Login to view more data
100 Deals associated with 3H (Suzhou) Pharmaceuticals Co., Ltd
Login to view more data
100 Translational Medicine associated with 3H (Suzhou) Pharmaceuticals Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
3HP-2827
 ( FGFR2 )		Solid tumor
More
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free